Cite
HARVARD Citation
Laverdure, E. et al. (2022). Refractory immune TTP following Pfizer‐BioNTech COVID‐19 vaccine successfully salvaged with caplacizumab. Journal of thrombosis and haemostasis. pp. 1696-1698. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Laverdure, E. et al. (2022). Refractory immune TTP following Pfizer‐BioNTech COVID‐19 vaccine successfully salvaged with caplacizumab. Journal of thrombosis and haemostasis. pp. 1696-1698. [Online].